About AliveCor
AliveCor is a digital health company pioneering accessible cardiac care through AI-enabled ECG technology. Founded on proprietary machine learning-powered ECG sensors, AliveCor delivers medical-grade heart data anytime, anywhere. The company's flagship Kardia product line includes KardiaMobile personal ECG devices for consumers, KardiaMobile 6L for clinical and research use, and Kardia 12L—the first portable 12-lead ECG system lighter than a smartphone. AliveCor's technology has recorded over 300 million ECGs worldwide and is backed by more than 200 clinical publications. The company serves multiple market segments: consumers seeking remote cardiac monitoring, healthcare professionals requiring real-time heart rhythm analysis, biopharma partners conducting clinical trials and safety monitoring, health systems implementing enterprise remote patient monitoring platforms, and payers and employers managing cardiac health costs. AliveCor's AI algorithms are FDA-cleared to detect up to 39 cardiac determinations including atrial fibrillation, bradycardia, tachycardia, myocardial infarction, and ischemia. The company's software ecosystem includes KardiaPro for clinical workflow integration, KardiaStation for point-of-care use, and KardiaComplete for comprehensive cardiac care management. With over 5 million lifetime users across 40+ countries, AliveCor is advancing its mission to transform cardiovascular care by improving diagnosis, treatment, and reducing disparities in cardiac care access.
Mission & Story
Mission
Advancing our mission with end-to-end cardiological care and services for consumers, patients, providers, and payers that use state-of-the-art tools to improve diagnosis and treatment and help reduce disparities in care
Clinical Focus
Medical conditions and clinical areas addressed by AliveCor.
Who It Serves
Milestones & Awards
Recent Milestones
Launch of Kardia 12L as first-of-its-kind portable 12-lead ECG system. Two-week trial program for eligible U.S. healthcare professionals. Presentation of Kardia 12L clinical study data at Heart Rhythm Society 2024. Launch of K1000 with InstantQT technology.
Awards & Recognition
Doctor-recommended personal ECG device. World's first FDA-cleared 6-lead personal ECG (KardiaMobile 6L). Most clinically validated personal ECG brand with 200+ publications.
Key Partnerships
Social & Media
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Caption Health, Inc
Caption Health develops AI-powered ultrasound guidance technology that enables healthcare providers to capture high-quality cardiac ultrasound images, expanding access to diagnostic imaging beyond traditional specialists.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.